关于SARS-CoV-2治疗的药物基因组研究:在COVID-19患者中识别与治疗反应相关的多形态
Alexandre Serra-Llovich1, Natalia Cullell1,2, Olalla Maroñas3,4,5
1Fundació Docència i Recerca Mutua Terrassa, 08221 Terrassa, Spain.
Biomedicines
|March 28, 2025
概括
主体遗传因素影响COVID-19治疗反应. 这项研究确定了16个影响免疫调节剂和皮质体治疗结果的基因,为未来流行病中的精准医学铺平了道路.
科学领域:
- 遗传学和基因组学 在
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于COVID-19大流行导致了全球显著的死亡率,突出显示了对有效治疗的需求.
- 目前的COVID-19疗法被重新使用,影响治疗反应的遗传因素被研究不足.
- 了解宿主遗传学对于预测感染性疾病的易感性和治疗结果至关重要.
研究的目的:
- 为了识别宿主遗传生物标志物,预测COVID-19药理疗法的临床结果.
- 调查遗传变异与患者对免疫调节剂和皮质类药物的反应之间的相关性.
主要方法:
- 基因组广泛关联研究 (GWAS) 和候选基因分析对来自SCOURGE队列的COVID-19患者进行.
- 患者接受了免疫调节剂 (n=849),皮质类药物 (n=2202) 或两者 (n=2487).
- 用90天生存率,ICU入院,放射学发现和通风类型等表型来评估治疗反应.
主要成果:
- 16个基因 (例如TLR1,TLR6,TLR10,CYP2C19,ACE2) 的显著多态化与治疗反应有关.
- 丰富分析确定了与先天免疫,药物ADME,病毒感染和编程细胞死亡相关的途径.
- 这些遗传变异可能会调节COVID-19患者对皮质类药物和免疫调节器疗法的反应.
结论:
- 这项研究为了解COVID-19治疗反应的遗传基础建立了一个框架.
- 已识别的遗传生物标志物为管理COVID-19和未来的流行病提供了个性化医疗方法的潜力.
- 对遗传决定因素的洞察力可以优化传染病的治疗策略.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
03:53Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
Published on: November 10, 2023
相关概念视频
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...